Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Acme Capital
AddedFeb 11, 2024
UpdatedJul 3, 2026
Acme Capital

Acme Capital

Operating

ACME Capital: A San Francisco-based venture capital firm, investing in disruptive technologies since 2018.

Location
Boca Raton, FL, US
Founded
2009
Firm
Compare
Portfolio
Employees
Website

Investments

Pier
Pier

Total Raised

$2.9M

Rounds

2

Seed$2.4MJanuary 2024
True Anomaly
True Anomaly

Total Raised

$158M

Rounds

5

Series B$100MDecember 2023
Conceivable Life Sciences
Conceivable Life Sciences

Total Raised

$20M

Rounds

1

Seed$20MAugust 2023
Slync
Slync

Total Raised

$100.5M

Rounds

7

Series Unknown$24.6MFebruary 2023
Series B$60MFebruary 2021
Reshape Biotech
Reshape Biotech
Seed

Total Raised

$13.2M

Rounds

3

Seed$7.1MFebruary 2023
BoomPop
BoomPop

Total Raised

$14M

Rounds

2

Series A$14MNovember 2022
Socket
Socket

Total Raised

$2M

Rounds

1

Pre-Seed$2MJuly 2022
Ever/Body
Ever/Body

Total Raised

$110.5M

Rounds

4

Series C$55.5MJune 2022
Series B$38MMay 2021
Crypto Unicorns
Crypto Unicorns

Total Raised

$26M

Rounds

1

Initial Coin Offering$26MMarch 2022
Laurel
Laurel

Total Raised

$55.7M

Rounds

6

Series B$36.5MMarch 2022
Petra
Petra

Total Raised

$33M

Rounds

3

Series A$30MDecember 2021
Tia
Tia

Total Raised

$132.8M

Rounds

6

Series B$100MSeptember 2021
Regology
Regology
Acquired

Total Raised

$8.1M

Rounds

2

Series A$8MAugust 2021
AviaGames
AviaGames

Total Raised

$48M

Rounds

2

Series B$40MAugust 2021
Huddles
Huddles

Total Raised

$8.9M

Rounds

4

Seed$4.3MJuly 2021
Seed$3.8MJanuary 2021
Favor
Favor
Acquired

Total Raised

$103.6M

Rounds

5

Series B$41.9MJune 2021
Xwing
Xwing

Total Raised

$54M

Rounds

5

Series B$40MApril 2021
Curology
Curology

Total Raised

$19.1M

Rounds

6

Series UnknownApril 2021
Symbio Robotics
Symbio Robotics

Total Raised

$29.3M

Rounds

5

Series B$14.6MFebruary 2021
SoLo Funds
SoLo Funds

Total Raised

$13M

Rounds

7

Series A$10MFebruary 2021
Uhnder
Uhnder

Total Raised

$45M

Rounds

3

Series C$45MDecember 2020
Braintrust
Braintrust

Total Raised

$123.5M

Rounds

5

Series Unknown$18MOctober 2020